Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.
Primary Care Research Group, IDIBAPS, Centre d'Assistència_Primària ABS Les Corts, GESCLINIC, Barcelona, Spain.
J Clin Transl Hepatol. 2013 Dec;1(2):94-102. doi: 10.14218/JCTH.2013.00011. Epub 2013 Dec 15.
Liver involvement was one of the first extraglandular manifestations to be reported in patients with primary Sjögren syndrome (SS). In the 1990s, a study of liver involvement in patients with primary SS integrated the evaluation of clinical signs of liver disease, liver function and a complete panel of autoantibodies. Recent developments in the field of hepatic and viral diseases have significantly changed the diagnostic approach to liver involvement in SS. The most recent studies have shown that, after eliminating hepatotoxic drugs and fatty liver disease, the two main causes of liver disease in primary SS are chronic viral infections and autoimmune liver diseases. The differential diagnosis of liver disease in primary SS (viral vs autoimmune) is clinically important, since the two processes require different therapeutic approaches and have different prognoses. With respect to viral infections, chronic HCV infection is the main cause of liver involvement in SS patients from the Mediterranean area, while chronic HBV infection may be the main cause of liver involvement in SS patients from Asian countries. After eliminating viral hepatitis, primary biliary cirrhosis (PBC) should be considered the main cause of liver disease in primary SS. PBC-related SS patients may have a broad spectrum of abnormalities of the liver, including having no clinical or analytical data suggestive of liver disease. Autoimmune hepatitis (AIH) is the second most frequently found autoimmune liver disease to be associated with SS (all reported cases are type I), and nearly 10% of these patients have an AIH-PBC overlap. Finally, IgG4-related disease must be investigated in patients with SS presenting with sclerosing cholangitis, especially when autoimmune pancreatitis or retroperitoneal fibrosis are also present.
肝脏受累是原发性干燥综合征(pSS)患者最早报道的腺外表现之一。20 世纪 90 年代,一项原发性干燥综合征患者肝脏受累的研究综合评估了肝脏疾病的临床征象、肝功能和全套自身抗体。近年来,肝脏和病毒性疾病领域的进展显著改变了原发性干燥综合征肝脏受累的诊断方法。最近的研究表明,在排除肝毒性药物和脂肪肝后,原发性干燥综合征中两种主要的肝脏疾病病因是慢性病毒感染和自身免疫性肝病。原发性干燥综合征肝脏疾病(病毒性与自身免疫性)的鉴别诊断具有重要的临床意义,因为这两种过程需要不同的治疗方法,且预后不同。在病毒性感染方面,慢性 HCV 感染是来自地中海地区的原发性干燥综合征患者肝脏受累的主要原因,而慢性 HBV 感染可能是来自亚洲国家的原发性干燥综合征患者肝脏受累的主要原因。在排除病毒性肝炎后,原发性胆汁性胆管炎(PBC)应被视为原发性干燥综合征的主要肝脏疾病病因。与 PBC 相关的干燥综合征患者可能有广泛的肝脏异常,包括没有提示肝脏疾病的临床或分析数据。自身免疫性肝炎(AIH)是与原发性干燥综合征相关的第二种最常见的自身免疫性肝病(所有报道的病例均为 I 型),近 10%的患者存在 AIH-PBC 重叠。最后,当存在自身免疫性胰腺炎或腹膜后纤维化时,应在有硬化性胆管炎表现的原发性干燥综合征患者中调查 IgG4 相关疾病。